Formulation, lyophilization and solid-state properties of a pegylated protein.

Mitra Mosharraf , Michael Malmberg , Jonas Fransson
International Journal of Pharmaceutics 336 ( 2) 215 -232

17
2007
Effective Approaches to Formulation Development of Biopharmaceuticals

Rajiv Nayar , Mitra Mosharraf
Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals 307 -328

2010
Accelerated dosing frequency of a pulmonary formulation of tissue plasminogen activator is well-tolerated in mice.

Kathleen A Stringer , Meghan Tobias , John S Dunn , Jackie Campos
Clinical and Experimental Pharmacology and Physiology 35 ( 12) 1454 -1460

8
2008
Apparent solubility of drugs in partially crystalline systems.

Mitra Mosharraf , Christer Nyström
Drug Development and Industrial Pharmacy 29 ( 6) 603 -622

38
2003
The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs

Mitra Mosharraf , Christer Nyström
International Journal of Pharmaceutics 122 ( 1-2) 35 -47

491
1995
Solubility characterization of practically insoluble drugs using the Coulter counter principle

Mitra Mosharraf , Christer Nyström
International Journal of Pharmaceutics 122 ( 1-2) 57 -67

10
1995
The effect of dry mixing on the apparent solubility of hydrophobic, sparingly soluble drugs

Mitra Mosharraf , Christer Nyström
European Journal of Pharmaceutical Sciences 9 ( 2) 145 -156

33
1999
The effects of disordered structure on the solubility and dissolution rates of some hydrophilic, sparingly soluble drugs

Mitra Mosharraf , Tesfai Sebhatu , Christer Nyström
International Journal of Pharmaceutics 177 ( 1) 29 -51

35
1999
EFFECT OF CALCIUM-IONS ON THE SURFACE-CHARGE AND AGGREGATION OF PHOSPHATIDYLCHOLINE LIPOSOMES

M. Mosharraf , K. M. G. Taylor , D. Q. M. Craig
Journal of Drug Targeting 2 ( 6) 541 -545

13
1995